Information, not a decision

Colorectal cancer: tumour board sheet

Dated public registry data. It contains no treatment recommendation. 13 Nov 2026

Open trials (2192)

NCT06589830	Phase 2	TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer	Recruiting
NCT07458347	Phase 1	A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation	Recruiting
NCT05195710	Phase 1	Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases	Recruiting
NCT01174121	Phase 2	Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer	Recruiting
NCT07931300	No phase	Multicenter Study of SIS Patch in High-risk Colorectal Anastomosis	Recruiting
NCT04907643	No phase	Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	Recruiting
NCT06997497	Phase 3	A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)	Recruiting
NCT04847063	Phase 1	Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies	Recruiting
NCT07912593	Phase 1/2	A KRAS Inhibitor in Participants With Advanced Solid Tumors	Recruiting
NCT07500298	Phase 1	Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer	Recruiting
NCT06270706	Phase 1	A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors	Recruiting
NCT06004245	Phase 1	A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors	Recruiting

2180 more in the doctor's list on the site.

Phase 3 trials that ended in the last 90 days

No phase 3 trial in this list ended in the last 90 days.

Guidelines

Links only: read the guideline itself.

Made from the public data of Frontlight Research. Source: ClinicalTrials.gov. 13 Nov 2026

https://frontlightresearch.com/en/doctor/colorectal-cancer/tumor-board